CD44 and urinary bladder carcinoma: For example, by siRNA-mediated silencing of GALNT1, which control O-linked glycosylation activation of SHH signaling in CD44+ CSCs in bladder cancer to mediate stemness, the tumor growth was suppressed in a similar extent to cyclopamine in an orthotopic mouse model of bladder cancer (34).